o | Preliminary Proxy Statement. | |
o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). | |
þ | Definitive Proxy Statement. | |
o | Definitive Additional Materials. | |
o | Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-12 |
þ | No fee required. | |
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. |
1) | Title of each class of securities to which transaction applies: | ||
2) | Aggregate number of securities to which transaction applies: | ||
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | ||
4) | Proposed maximum aggregate value of transaction: | ||
5) | Total fee paid: | ||
o | Fee paid previously with preliminary materials. | |
o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
1) | Amount Previously Paid: | ||
2) | Form, Schedule or Registration Statement No.: | ||
3) | Filing Party: | ||
4) | Date Filed: | ||
Q. | Why am I receiving this Proxy Statement? |
A. | You are being asked to vote on a number of important matters: |
(i) | Elimination of Fundamental Investment Policies and Approval of New Fundamental Investment Policy (Insured Funds only). Fund shareholders are being asked to approve the elimination of certain fundamental investment policies and to approve a new fundamental policy. These changes are designed to give the Insured Funds important flexibility to respond to on-going developments in the bond insurance market while maintaining their current focus on insured bonds backed by insurers with solid credit ratings; |
(ii) | Approval of Fund Board Nominees (All Funds). Each year, you and other Fund shareholders must approve the election of Board members to serve on your Funds Board. This is a requirement for all funds that list their common shares on a stock exchange. The Funds described in this proxy statement are holding their annual shareholder meetings at which Board members will be elected. The list of specific nominees is contained in the enclosed proxy; and |
(iii) | Ratification of Independent Auditors (Nuveen Core Equity Alpha Fund only). Fund shareholders are being asked to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Fund. |
Q. | Why are shareholders of the Insured Funds being asked to approve the elimination of fundamental investment policies and to approve a new fundamental investment policy? |
A. | As a result of conditions facing the bond insurance market, shareholders are being asked to approve the elimination of certain fundamental investment policies that are restricting, or may be expected in the future to restrict, each Insured Funds ability to effectively maintain its existing focus on insured bonds backed by insurers with solid credit ratings. In connection with eliminating the fundamental investment policies, shareholders are being asked to approve a new fundamental investment policy that will provide the Insured Funds with flexibility to respond to on-going developments in the bond insurance market, while ensuring that the Insured Funds continue to invest substantially all (at least 80%) of their investments in insured bonds backed by insurers with solid credit ratings. |
Q. | What happens if shareholders dont approve the elimination of the fundamental investment policies and/or dont approve the new fundamental investment policy? |
A. | If shareholders do not approve the elimination of the fundamental investment policies, then the Board will take such action as it deems to be in the best interest of each Insured Fund. In addition, the elimination of each fundamental policy (i), as described in the enclosed proxy statement, is contingent on shareholder approval of the new fundamental policy and the implementation of the new fundamental investment policy is contingent on shareholder approval of the elimination of fundamental policy (i). Your Funds Board urges you to vote without delay in order to avoid potential disruption to the Funds operations. |
Q. | Who do I call if I have questions? |
A. | If you need any assistance, or have any questions regarding the proposals or how to vote your shares, please call Computershare Fund Services, your Fund proxy solicitor, at (866) 434-7510. Please have your proxy material available when you call. |
Q. | How do I vote my shares? |
A. | You can vote your shares by completing and signing the enclosed proxy card, and mailing it in the enclosed postage-paid envelope. Alternatively, you may vote by telephone by calling the toll-free number on the proxy card or by computer by going to the Internet address provided on the proxy card and following the instructions, using your proxy card as a guide. |
Q. | Will anyone contact me? |
A. | You may receive a call from Computershare Fund Services, the proxy solicitor hired by your Fund, to verify that you received your proxy materials, to answer any questions you may have about the proposals and to encourage you to vote your proxy. |
1. | To elect Members to the Board of Directors/Trustees (each a Board and each Director or Trustee a Board Member) of each Fund as outlined below: |
a. | For each Massachusetts Business Trust, except Core Equity, Equity Premium, Equity Premium Advantage, Equity Premium Income, Equity Premium Opportunity, Global Government, Global Value and Multi-Currency, to elect five (5) Board Members. |
i) | three (3) Class II Board Members to be elected by the holders of Common Shares and FundPreferred shares for Quality Preferred, Quality Preferred 2, Quality Preferred 3, Real Estate, Diversified Dividend, Tax-Advantaged, Multi-Strategy and |
Multi-Strategy 2; and Municipal Auction Rate Cumulative Preferred Shares for each other Fund (collectively, Preferred Shares), voting together as a single class; and |
ii) | two (2) Board Members to be elected by the holders of Preferred Shares only, voting separately as a single class. |
b. | For Core Equity, Equity Premium, Equity Premium Advantage, Equity Premium Income, Equity Premium Opportunity, Global Government, Global Value and Multi-Currency to elect three (3) Class II Board Members and one (1) Class I Board Member. |
c. | For each Minnesota Corporation, except New York Value, to elect nine (9) Board Members. |
i) | seven (7) Board Members to be elected by the holders of Common Shares and Preferred Shares, voting together as a single class; and |
ii) | two (2) Board Members to be elected by the holders of Preferred Shares only, voting separately as a single class. |
d. | For New York Value, to elect three (3) Class II Board Members and one (1) Class I Board Member. |
2. | To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Core Equity. |
3. | To approve the elimination of fundamental investment policies and to approve the new fundamental investment policy for Insured New York Premium, Insured Premium Income 2, Insured Municipal Opportunity, Premier Insured, Insured Quality, New York Quality, New York Select, Insured New York Tax-Free, Insured Dividend Advantage, Insured Tax-Free Advantage, New York Investment Quality and Insured New York Dividend. |
4. | To transact such other business as may properly come before the Annual Meeting. |
1
2
Matter | Common Shares | Preferred Shares(1) | ||||
1a(i).
|
For each Massachusetts Business Trust, election of three (3) Class II Board Members by all shareholders (except Core Equity, Equity Premium, Equity Premium Opportunity, Equity Premium Advantage, Equity Premium Income, Global Government, Global Value and Multi-Currency). | X | X | |||
1a(ii).
|
For each Massachusetts Business Trust, election of two (2) Board Members by Preferred Shares only (except Core Equity, Equity Premium, Equity Premium Opportunity, Equity Premium Advantage, Equity Premium Income, Global Government, Global Value and Multi-Currency). | X | ||||
1b.
|
For Core Equity, Equity Premium, Equity Premium Opportunity, Equity Premium Advantage, Equity Premium Income, Global Government, Global Value, Tax-Advantaged Dividend and Multi-Currency, election of three (3) Class II Board Members and one (1) Class I Board Member by all shareholders. | X | N/A | |||
1c(i).
|
For each Minnesota Corporation, election of seven (7) Board Members by all shareholders (except New York Value). | X | X | |||
1c(ii).
|
For each Minnesota Corporation, election of two (2) Board Members by Preferred Shares only (except New York Value). | X | ||||
1d.
|
For New York Value, election of three (3) Class II Board Members and one (1) Class I Board Member by all shareholders. | X | N/A | |||
2.
|
For Core Equity, ratification of independent registered public accounting firm. | X | N/A | |||
3
Matter | Common Shares | Preferred Shares(1) | ||||
3.
|
For Insured New York Premium, Insured Premium Income 2, Insured Municipal Opportunity, Premier Insured, Insured Quality, New York Quality, New York Select, Insured New York Tax-Free, Insured Dividend Advantage, Insured Tax-Free Advantage, New York Investment Quality and Insured New York Dividend, to approve the elimination of fundamental investment policies and to approve a new fundamental investment policy. | X | X | |||
(1) | FundPreferred shares for Real Estate, Diversified Dividend, Quality Preferred, Quality Preferred 2, Quality Preferred 3, Tax-Advantaged, Multi-Strategy and Multi-Strategy 2; and Municipal Auction Rate Cumulative Preferred Shares (MuniPreferred) for each other Fund are referred to as Preferred Shares. |
4
Fund | Ticker Symbol(1) | Common Shares | Preferred Shares | |||||||||||||
New York Dividend | NAN | 9,265,330 | Series F | 2,760 | ||||||||||||
New York Dividend 2 | NXK | 6,495,716 | Series W | 1,880 | ||||||||||||
New York Investment Quality | NQN | 17,601,933 | Series M | 960 | ||||||||||||
Series T | 2,400 | |||||||||||||||
Series F | 2,400 | |||||||||||||||
New York Value | NNY | 15,120,364 | N/A | |||||||||||||
New York Performance Plus | NNP | 15,067,371 | Series M | 1,600 | ||||||||||||
Series T | 800 | |||||||||||||||
Series W | 2,000 | |||||||||||||||
Series F | 572 | |||||||||||||||
New York Quality | NUN | 23,904,439 | Series M | 2,200 | ||||||||||||
Series W | 2,200 | |||||||||||||||
Series TH | 2,400 | |||||||||||||||
Series F | 1,080 | |||||||||||||||
New York Select | NVN | 23,310,802 | Series T | 1,720 | ||||||||||||
Series W | 2,400 | |||||||||||||||
Series TH | 3,600 | |||||||||||||||
Insured Dividend Advantage | NVG | 29,813,300 | Series M | 3,160 | ||||||||||||
Series T | 3,080 | |||||||||||||||
Series TH | 3,080 | |||||||||||||||
5
Fund | Ticker Symbol(1) | Common Shares | Preferred Shares | |||||||||||||
Insured Municipal Opportunity | NIO | 81,138,037 | Series M | 4,000 | ||||||||||||
Series T | 4,000 | |||||||||||||||
Series W1 | 4,000 | |||||||||||||||
Series W2 | 3,200 | |||||||||||||||
Series TH1 | 4,000 | |||||||||||||||
Series TH2 | 4,000 | |||||||||||||||
Series F | 4,000 | |||||||||||||||
Insured Premium Income 2 | NPX | 37,353,512 | Series M | 2,080 | ||||||||||||
Series T | 2,200 | |||||||||||||||
Series W | 2,080 | |||||||||||||||
Series TH | 2,200 | |||||||||||||||
Series F | 2,196 | |||||||||||||||
Insured Quality | NQI | 38,296,617 | Series M | 2,600 | ||||||||||||
Series T | 2,600 | |||||||||||||||
Series W | 2,600 | |||||||||||||||
Series TH | 2,320 | |||||||||||||||
Series F | 2,600 | |||||||||||||||
Insured Tax-Free Advantage | NEA | 18,525,697 | Series T | 2,880 | ||||||||||||
Series W | 2,880 | |||||||||||||||
Insured New York Dividend | NKO | 7,964,131 | Series TH | 2,440 | ||||||||||||
Insured New York Premium | NNF | 8,329,215 | Series M | 1,320 | ||||||||||||
Series T | 1,280 | |||||||||||||||
Insured New York Tax-Free | NRK | 3,513,360 | Series TH | 1,080 | ||||||||||||
Premier Insured | NIF | 19,419,608 | Series W | 840 | ||||||||||||
Series TH | 2,800 | |||||||||||||||
Series F | 2,800 | |||||||||||||||
Core Equity | JCE | 16,443,986 | N/A | |||||||||||||
Real Estate | JRS | 28,302,032 | Series M | 1,104 | ||||||||||||
Series T | 1,104 | |||||||||||||||
Series W | 1,104 | |||||||||||||||
Series TH | 1,264 | |||||||||||||||
Series F | 1,104 | |||||||||||||||
Diversified Dividend | JDD | 20,202,819 | Series T | 2,400 | ||||||||||||
Series W | 2,400 | |||||||||||||||
Equity Premium | JPG | 16,536,342 | N/A | |||||||||||||
Equity Premium Advantage | JLA | 26,114,541 | N/A | |||||||||||||
Equity Premium Income | JPZ | 38,682,087 | N/A | |||||||||||||
Equity Premium Opportunity | JSN | 66,537,837 | N/A | |||||||||||||
Quality Preferred | JTP | 64,567,649 | Series M | 3,520 | ||||||||||||
Series T | 3,520 | |||||||||||||||
Series W | 3,520 | |||||||||||||||
Series TH | 3,520 | |||||||||||||||
Series F | 3,520 | |||||||||||||||
6
Fund | Ticker Symbol(1) | Common Shares | Preferred Shares | |||||||||||||
Quality Preferred 2 | JPS | 119,845,699 | Series M | 4,800 | ||||||||||||
Series T | 4,800 | |||||||||||||||
Series T2 | 4,000 | |||||||||||||||
Series W | 4,800 | |||||||||||||||
Series TH | 4,800 | |||||||||||||||
Series TH2 | 4,000 | |||||||||||||||
Series F | 4,800 | |||||||||||||||
Quality Preferred 3 | JHP | 23,695,161 | Series M | 3,320 | ||||||||||||
Series TH | 3,320 | |||||||||||||||
Tax-Advantaged | JTA | 13,958,267 | Series W | 1,800 | ||||||||||||
Tax-Advantaged Dividend | JTD | 14,758,340 | N/A | |||||||||||||
Global Government | JGG | 9,330,610 | N/A | |||||||||||||
Global Value | JGV | 19,355,240 | N/A | |||||||||||||
Multi-Currency | JGT | 44,467,793 | N/A | |||||||||||||
Multi-Strategy | JPC | 99,403,528 | Series M | 3,020 | ||||||||||||
Series T | 3,020 | |||||||||||||||
Series W | 3,020 | |||||||||||||||
Series TH | 3,020 | |||||||||||||||
Series F | 3,020 | |||||||||||||||
Series F2 | 3,020 | |||||||||||||||
Multi-Strategy 2 | JQC | 139,731,300 | Series M | 3,860 | ||||||||||||
Series M2 | 3,860 | |||||||||||||||
Series T | 3,860 | |||||||||||||||
Series T2 | 3,860 | |||||||||||||||
Series W | 3,860 | |||||||||||||||
Series W2 | 3,860 | |||||||||||||||
Series TH | 3,860 | |||||||||||||||
Series TH2 | 3,860 | |||||||||||||||
Series F | 3,860 | |||||||||||||||
Series F2 | 3,860 | |||||||||||||||
(1) | The common shares of all of the Funds are listed on the New York Stock Exchange, except NEA, NXK, NKO, NRK, NVG and JRS, which are listed on the American Stock Exchange. |
7
a. | For each Massachusetts Business Trust (except Core Equity, Equity Premium, Equity Premium Advantage, Equity Premium Income, Equity Premium Opportunity, Global Government, Global Value, Tax-Advantaged Dividend and Multi-Currency): |
(i) | three (3) Board Members are to be elected by holders of Common Shares and Preferred Shares, voting together as a single class. Board Member nominees Amboian and Toth and Board Member Kundert have been designated as Class II Board Members, and as nominees for Board Members for a term expiring at the annual meeting of shareholders in 2011 or until their successors have been duly elected and qualified. Board Members Bremner, Evans, Stockdale and Stone are current and continuing Board Members. Board Members Bremner and Evans have been designated as Class III Board Members for a term expiring at the annual meeting of shareholders in 2009 or until their successors have been duly elected and qualified. Board Members Stockdale and Stone have been designated as Class I Board Members for a term expiring at the annual meeting of shareholders in 2010 or until their successors have been duly elected and qualified. |
(ii) | two (2) Board Members are to be elected by holders of Preferred Shares, voting separately as a single class. Board Members Hunter and Schneider are nominees for election by holders of Preferred Shares for a term expiring at the next annual meeting or until their successors have been duly elected and qualified. |
b. | For Core Equity, Equity Premium, Equity Premium Advantage, Equity Premium Income, Equity Premium Opportunity, Global Government, Global Value, Tax-Advantaged Dividend and Multi-Currency: |
(i) | four (4) Board Members are to be elected by all shareholders. Board Member nominees Amboian and Toth and Board Member Kundert have been designated as Class II Board Members, and as nominees for Board Members for a term expiring at the annual meeting of shareholders in 2011 or until their successors have been duly elected and qualified. Board Member Hunter has been re-designated as a Class I Board Member, and as a nominee for Board Member for a term expiring at the annual meeting of shareholders in 2010, or until his successor has been duly elected and qualified. Board Members Bremner, Evans, Schneider, Stockdale and Stone are current and continuing Board Members. Board Members Bremner, Evans and Schneider have been designated as Class III Board Members for a term expiring at the annual meeting of shareholders in 2009 or until their successors have been duly elected and qualified. Board Members Stockdale and Stone have been designated as Class I Board Members for a term expiring at the annual meeting of shareholders in 2010 or until their successors have been duly elected and qualified. |
8
c. | For each Minnesota Corporation, except New York Value: |
(i) | seven (7) Board Members are to be elected by holders of Common Shares and Preferred Shares, voting together as a single class. Board Member nominees Amboian and Toth and Board Members Bremner, Evans, Kundert, Stockdale and Stone are nominees for election by all shareholders. |
(ii) | two (2) Board Members are to be elected by holders of Preferred Shares. Board Members Hunter and Schneider are nominees for election by holders of Preferred Shares. |
d. | For New York Value: The Board of New York Value has designated Board Member nominees Amboian and Toth and Board Member Kundert as Class II Board Members and as nominees for Board Members for a term expiring at the annual meeting of shareholders in 2011 and has re-designated Board Member Hunter as a Class I Board Member, and as a nominee for Board Member for a term expiring at the annual meeting of shareholders in 2010 or until their successors have been duly elected and qualified. The remaining Board Members Bremner, Evans, Schneider, Stockdale and Stone are current and continuing Board Members. Board Members Bremner, Evans and Schneider have been designated as Class III Board Members for terms expiring in 2009 or until their successors have been duly elected and qualified. Board Members Stockdale and Stone have been designated as Class I Board Members for a term expiring at the annual meeting of shareholders in 2010 or until their successors have been duly elected and qualified. |
9
10
Number of |
||||||||||||
Portfolios |
||||||||||||
in Fund |
Other |
|||||||||||
Complex |
Director- |
|||||||||||
Position(s) |
Term of Office |
Overseen |
ships Held |
|||||||||
Name, Address |
Held with |
and Length |
Principal Occupation(s) |
by Board |
by Board |
|||||||
and Birth Date | Fund | of Time Served(1) | During Past 5 Years | Member | Member | |||||||
Nominees/Board Members who are not interested persons of the
Fund
|
||||||||||||
Robert P. Bremner c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (8/22/40) |
Board Member; Lead Independent Director |
Term: Annual or Class III Board Member until 2009 Length of Service: Since 1996; Lead Independent Director Since 2005 |
Private Investor and Management Consultant. | 184 | N/A | |||||||
Jack B. Evans c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (10/22/48) |
Board Member |
Term: Annual or Class III Board Member until 2009 Length of Service: Since 1999 |
President, The Hall-Perrine Foundation, a private philanthropic corporation (since 1996); Director and Vice Chairman, United Fire Group, a publicly held company; Member of the Board of Regents for the State of Iowa University System; Director, Gazette Companies; Life Trustee of Coe College and Iowa College Foundation; Member of the Advisory Council of the Department of Finance in the Tippie College of Business, University of Iowa; formerly, Director, Alliant Energy; formerly, Director, Federal Reserve Bank of Chicago; formerly, President and Chief Operating Officer, SCI Financial Group, Inc., a regional financial services firm. | 184 | See Principal Occupation Description | |||||||
William C. Hunter c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (3/6/48) |
Board Member |
Term: Annual or Class I Board Member until 2010 Length of Service: Since 2004 |
Dean, Tippie College of Business, University of Iowa (since July 2006); Director, Credit Research Center at George Washington University; Director (since 2004) of Xerox Corporation, a publicly held company; Director, Beta Gamma Sigma International Honor Society (since 2005); formerly, (2003-2006), Dean and Distinguished Professor of Finance, School of Business at the University of Connecticut; formerly, Senior Vice President and Director of Research at the Federal Reserve Bank of Chicago (1995-2003); formerly, Director, SS&C Technologies, Inc. (May 2005-October 2005). | 184 | See Principal Occupation Description | |||||||
David J.
Kundert(2) c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (10/28/42) |
Board Member |
Term: Annual or Class II Board Member until 2011 Length of Service: Since 2005 |
Director, Northwestern Mutual Wealth Management Company; retired (2004) as Chairman, JPMorgan Fleming Asset Management, President and CEO, Banc One Investment Advisors Corporation, and President, One Group Mutual Funds; prior thereto, Executive Vice President, Bank One Corporation and Chairman and CEO, Banc One Investment Management Group; Board of Regents, Luther College; member of the Wisconsin Bar Association; member of Board of Directors, Friends of Boerner Botanical Gardens; member of Investment Committee, Greater Milwaukee Foundation. | 184 | See Principal Occupation Description |
11
Number of |
||||||||||||
Portfolios |
||||||||||||
in Fund |
Other |
|||||||||||
Complex |
Director- |
|||||||||||
Position(s) |
Term of Office |
Overseen |
ships Held |
|||||||||
Name, Address |
Held with |
and Length |
Principal Occupation(s) |
by Board |
by Board |
|||||||
and Birth Date | Fund | of Time Served(1) | During Past 5 Years | Member | Member | |||||||
William J. Schneider c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (9/24/44) |
Board Member |
Term: Annual or Class III Board Member until 2009 Length of Service: Since 1996 |
Chairman, formerly, Senior Partner and Chief Operating Officer (retired, 2004) of Miller-Valentine Partners Ltd., a real estate investment company; Director, Dayton Development Coalition; formerly, member, Business Advisory Council, Cleveland Federal Reserve Bank. | 184 | See Principal Occupation Description | |||||||
Judith M. Stockdale c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (12/29/47) |
Board Member |
Term: Annual or Class I Board Member until 2010 Length of Service: Since 1997 |
Executive Director, Gaylord and Dorothy Donnelley Foundation (since 1994); prior thereto, Executive Director, Great Lakes Protection Fund (from 1990 to 1994). | 184 | N/A | |||||||
Carole E. Stone c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (6/28/47) |
Board Member |
Term: Annual or Class I Board Member until 2010 Length of Service: Since 2007 |
Director, Chicago Board Options Exchange (since 2006); Chair, New York Racing Association Oversight Board (2005-12/2007); Commissioner, NYSE Commission on Public Authority Reform (since 2005); formerly Director, New York State Division of the Budget (2000-2004), Chair, Public Authorities Control Board (2000-2004) and Director, Local Government Assistance Corporation (2000-2004). | 184 | See Principal Occupation Description | |||||||
Terence J. Toth c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (9/29/59) |
Board Member Nominee |
Term: Annual or Class II Board Member until 2011 Length of Service: Standing for Initial Election |
Private Investor (since 2007); CEO and President, Northern Trust Investments (2004-2007); Executive Vice President, Quantitative Management & Securities Lending (2000-2004); prior thereto, various positions with Northern Trust Company (since 1994); Member: Goodman Theatre Board (since 2004); Chicago Fellowship Board (since 2005), University of Illinois Leadership Council Board (since 2007) and Catalyst Schools of Chicago Board (since 2008); formerly Member: Northern Trust Mutual Funds Board (2005-2007), Northern Trust Japan Board (2004-2007), Northern Trust Securities Inc. Board (2003-2007) and Northern Trust Hong Kong Board (1997-2004). | 333 | See Principal Occupation Description | |||||||
Nominee/Board Member who is an interested person of the
Fund
|
||||||||||||
John P.
Amboian(4) c/o Nuveen Investments, Inc. 333 West Wacker Drive Chicago, IL 60606 (6/14/61) |
Board Member |
Term: Annual or Class II Board Member until 2011 Length of Service: Standing for Initial Election |
Chief Executive Officer (since July 2007) and Director (since 1999) of Nuveen Investments, Inc.; Chief Executive Officer (since 2007) of Nuveen Asset Management, Rittenhouse Asset Management, Nuveen Investments Advisers, Inc. formerly, President (1999-2004) of Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp.(5) | 333 | See Principal Occupation Description | |||||||
(1) | Length of Service indicates the year in which the individual became a Board Member of a fund in the Nuveen fund complex. |
(2) | Currently an Interested person as defined in the 1940 Act of Real Estate and Diversified Dividend by reason of his ownership of shares of the parent company of those Funds sub-adviser. However, as indicated above, it is expected that Mr. Kundert will not be an interested person of Real Estate and Diversified Dividend as of the time of the Annual Meeting. |
(3) | Mr. Amboian and Mr. Toth are standing for election as a Board Member for 33 Funds holding their Annual Meeting on June 30, 2008. In addition, Mr. Amboian and Mr. Toth have been appointed as a Board member to an additional 151 Funds in the Nuveen complex, which appointment will become effective on July 1, 2008. |
12
(4) | Interested person as defined in the 1940 Act, by reason of being an officer of each Funds adviser. |
(5) | Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp. were reorganized into Nuveen Asset Management, effective January 1, 2005. |
13
14
15
Aggregate Compensation from the Funds(1) | ||||||||||||||||||||||||||||||||
Robert P. |
Jack B. |
William C. |
David J. |
William J. |
Judith M. |
Carole E. |
Terence |
|||||||||||||||||||||||||
Fund | Bremner | Evans | Hunter | Kundert | Schneider | Stockdale | Stone | J. Toth | ||||||||||||||||||||||||
New York Dividend
|
584 | 558 | 446 | 490 | 551 | 469 | 221 | 0 | ||||||||||||||||||||||||
New York Dividend 2
|
402 | 384 | 307 | 337 | 379 | 323 | 153 | 0 | ||||||||||||||||||||||||
New York Investment Quality
|
1,146 | 1,098 | 918 | 937 | 1,144 | 950 | 431 | 0 | ||||||||||||||||||||||||
New York Value
|
421 | 402 | 321 | 353 | 397 | 338 | 160 | 0 | ||||||||||||||||||||||||
New York Performance Plus
|
1,012 | 970 | 811 | 828 | 1,011 | 839 | 381 | 0 | ||||||||||||||||||||||||
New York Quality
|
1,562 | 1,497 | 1,252 | 1,278 | 1,560 | 1,295 | 588 | 0 | ||||||||||||||||||||||||
New York Select
|
1,539 | 1,475 | 1,233 | 1,259 | 1,537 | 1,276 | 579 | 0 | ||||||||||||||||||||||||
Insured Dividend Advantage
|
1,904 | 1,828 | 1,550 | 1,543 | 1,929 | 1,590 | 698 | 0 | ||||||||||||||||||||||||
Insured Municipal Opportunity
|
5,322 | 5,109 | 4,332 | 4,313 | 5,390 | 4,443 | 1,950 | 0 | ||||||||||||||||||||||||
Insured Premium Income 2
|
2,188 | 2,101 | 1,781 | 1,773 | 2,216 | 1,827 | 802 | 0 | ||||||||||||||||||||||||
Insured Quality
|
2,487 | 2,388 | 2,024 | 2,016 | 2,519 | 2,076 | 912 | 0 | ||||||||||||||||||||||||
Aggregate Compensation from the Funds(1) | ||||||||||||||||||||||||||||||||
Robert P. |
Jack B. |
William C. |
David J. |
William J. |
Judith M. |
Carole E. |
Terence |
|||||||||||||||||||||||||
Fund | Bremner | Evans | Hunter | Kundert | Schneider | Stockdale | Stone | J. Toth | ||||||||||||||||||||||||
Insured Tax-Free Advantage
|
1,157 | 1,110 | 941 | 937 | 1,171 | 965 | 425 | 0 | ||||||||||||||||||||||||
Insured New York Dividend
|
504 | 482 | 385 | 423 | 476 | 406 | 192 | 0 | ||||||||||||||||||||||||
Insured New York Premium
|
530 | 506 | 405 | 445 | 500 | 426 | 201 | 0 | ||||||||||||||||||||||||
Insured New York Tax-Free
|
219 | 209 | 167 | 184 | 207 | 176 | 83 | 0 | ||||||||||||||||||||||||
Premier Insured
|
1,259 | 1,209 | 1,025 | 1,021 | 1,275 | 1,051 | 461 | 0 | ||||||||||||||||||||||||
Core Equity
|
524 | 1,370 | 300 | 327 | 333 | 1,394 | 340 | 0 | ||||||||||||||||||||||||
Real Estate
|
4,870 | 4,653 | 3,191 | 3,946 | 3,455 | 3,526 | 3,058 | 0 | ||||||||||||||||||||||||
Diversified Dividend
|
2,329 | 2,214 | 1,463 | 1,861 | 1,615 | 1,624 | 1,363 | 0 | ||||||||||||||||||||||||
Equity Premium
|
1,104 | 1,039 | 839 | 858 | 936 | 923 | 524 | 0 | ||||||||||||||||||||||||
Equity Premium Advantage
|
1,620 | 1,524 | 1,232 | 1,259 | 1,373 | 1,355 | 768 | 0 | ||||||||||||||||||||||||
Equity Premium Income
|
2,437 | 2,292 | 1,853 | 1,894 | 2,066 | 2,037 | 1,151 | 0 | ||||||||||||||||||||||||
16
Aggregate Compensation from the Funds(1) | ||||||||||||||||||||||||||||||||
Robert P. |
Jack B. |
William C. |
David J. |
William J. |
Judith M. |
Carole E. |
Terence |
|||||||||||||||||||||||||
Fund | Bremner | Evans | Hunter | Kundert | Schneider | Stockdale | Stone | J. Toth | ||||||||||||||||||||||||
Equity Premium Opportunity
|
4,154 | 3,908 | 3,158 | 3,229 | 3,520 | 3,473 | 1,971 | 0 | ||||||||||||||||||||||||
Quality Preferred
|
3,498 | 3,239 | 2,468 | 2,598 | 2,879 | 2,771 | 2,077 | 0 | ||||||||||||||||||||||||
Quality Preferred 2
|
6,618 | 6,130 | 4,669 | 4,916 | 5,448 | 5,244 | 3,929 | 0 | ||||||||||||||||||||||||
Quality Preferred 3
|
1,303 | 1,207 | 919 | 968 | 1,072 | 1,032 | 774 | 0 | ||||||||||||||||||||||||
Tax-Advantaged
|
1,747 | 1,642 | 980 | 1,351 | 1,140 | 1,102 | 837 | 0 | ||||||||||||||||||||||||
Tax-Advantaged Dividend
|
405 | 436 | 163 | 186 | 178 | 623 | 163 | 0 | ||||||||||||||||||||||||
Global Government
|
479 | 447 | 365 | 405 | 438 | 388 | 281 | 0 | ||||||||||||||||||||||||
Global Value
|
1,176 | 1,097 | 759 | 909 | 989 | 955 | 752 | 0 | ||||||||||||||||||||||||
Multi-Currency
|
1,280 | 1,111 | 877 | 987 | 993 | 1,086 | 933 | 0 | ||||||||||||||||||||||||
Multi-Strategy
|
6,130 | 5,712 | 3,888 | 4,635 | 5,099 | 4,961 | 3,871 | 0 | ||||||||||||||||||||||||
Multi-Strategy 2
|
8,568 | 7,984 | 5,434 | 6,478 | 7,126 | 6,935 | 5,412 | 0 | ||||||||||||||||||||||||
Total Compensation from Nuveen Funds Paid to Board
Members/Nominees
|
204,141 | 193,523 | 141,423 | 155,655 | 169,137 | 162,064 | 120,250 | 0 | ||||||||||||||||||||||||
(1) | Includes deferred fees. Pursuant to a deferred compensation agreement with certain of the Funds, deferred amounts are treated as though an equivalent dollar amount has been invested in shares of one or more eligible Nuveen funds. Total deferred fees for the Funds (including the return from the assumed investment in the eligible Nuveen funds) payable are: |
Deferred Fees | ||||||||||||||||||||||||||||||||
Robert P. |
Jack B. |
William C. |
David J. |
William J. |
Judith M. |
Carole E. |
Terence |
|||||||||||||||||||||||||
Fund | Bremner | Evans | Hunter | Kundert | Schneider | Stockdale | Stone | J. Toth | ||||||||||||||||||||||||
New York Investment Quality
|
180 | 284 | 918 | 937 | 1,144 | 538 | 0 | 0 | ||||||||||||||||||||||||
New York Performance Plus
|
159 | 251 | 811 | 828 | 1,011 | 475 | 0 | 0 | ||||||||||||||||||||||||
New York Quality Income
|
245 | 387 | 1,252 | 1,278 | 1,560 | 733 | 0 | 0 | ||||||||||||||||||||||||
New York Select Quality
|
241 | 381 | 1,233 | 1,259 | 1,537 | 722 | 0 | 0 | ||||||||||||||||||||||||
Insured Dividend Advantage
|
304 | 479 | 1,550 | 1,543 | 1,929 | 911 | 0 | 0 | ||||||||||||||||||||||||
Insured Municipal Opportunity
|
849 | 1,340 | 4,332 | 4,313 | 5,390 | 2,547 | 0 | 0 | ||||||||||||||||||||||||
Insured Premium Income 2
|
349 | 551 | 1,781 | 1,773 | 2,216 | 1,047 | 0 | 0 | ||||||||||||||||||||||||
Insured Quality
|
397 | 626 | 2,024 | 2,016 | 2,519 | 1,190 | 0 | 0 | ||||||||||||||||||||||||
Insured Tax-Free Advantage
|
184 | 291 | 941 | 937 | 1,171 | 553 | 0 | 0 | ||||||||||||||||||||||||
Premier Insured
|
201 | 317 | 1,025 | 1,021 | 1,275 | 603 | 0 | 0 | ||||||||||||||||||||||||
Core Equity Alpha
|
70 | 312 | 300 | 327 | 333 | 586 | 0 | 0 | ||||||||||||||||||||||||
Real Estate Income
|
670 | 1,081 | 3,191 | 3,946 | 3,455 | 1,600 | 0 | 0 | ||||||||||||||||||||||||
Diversified Dividend and Income
|
321 | 515 | 1,463 | 1,861 | 1,615 | 745 | 0 | 0 | ||||||||||||||||||||||||
17
Deferred Fees | ||||||||||||||||||||||||||||||||
Robert P. |
Jack B. |
William C. |
David J. |
William J. |
Judith M. |
Carole E. |
Terence |
|||||||||||||||||||||||||
Fund | Bremner | Evans | Hunter | Kundert | Schneider | Stockdale | Stone | J. Toth | ||||||||||||||||||||||||
Equity Premium and Growth
|
153 | 243 | 839 | 858 | 936 | 476 | 0 | 0 | ||||||||||||||||||||||||
Equity Premium Advantage
|
225 | 357 | 1,232 | 1,259 | 1,373 | 699 | 0 | 0 | ||||||||||||||||||||||||
Equity Premium Income
|
338 | 537 | 1,853 | 1,894 | 2,066 | 1,052 | 0 | 0 | ||||||||||||||||||||||||
Equity Premium Opportunity
|
576 | 915 | 3,158 | 3,229 | 3,520 | 1,791 | 0 | 0 | ||||||||||||||||||||||||
Quality Preferred Income
|
483 | 754 | 2,468 | 2,598 | 2,879 | 1,315 | 0 | 0 | ||||||||||||||||||||||||
Quality Preferred Income 2
|
914 | 1,427 | 4,669 | 4,916 | 5,448 | 2,489 | 0 | 0 | ||||||||||||||||||||||||
Quality Preferred Income 3
|
180 | 281 | 919 | 968 | 1,072 | 490 | 0 | 0 | ||||||||||||||||||||||||
Tax-Advantaged Total Return Strategy
|
243 | 384 | 980 | 1,351 | 1,140 | 520 | 0 | 0 | ||||||||||||||||||||||||
Global Value Opportunities
|
128 | 202 | 565 | 726 | 763 | 330 | 0 | 0 | ||||||||||||||||||||||||
Multi-Currency Short-Term Government Income
|
76 | 121 | 404 | 458 | 425 | 202 | 0 | 0 | ||||||||||||||||||||||||
Multi-Strategy Income & Growth
|
849 | 1,334 | 3,888 | 4,635 | 5,099 | 2,333 | 0 | 0 | ||||||||||||||||||||||||
Multi-Strategy Income & Growth 2
|
1,186 | 1,864 | 5,434 | 6,478 | 7,126 | 3,261 | 0 | 0 | ||||||||||||||||||||||||
18
19
20
21
Number of |
||||||||||
Term of |
Portfolios |
|||||||||
Office and |
in Fund |
|||||||||
Position(s) |
Length of |
Complex |
||||||||
Name, Address |
Held |
Time |
Principal Occupation(s) |
Served by |
||||||
and Birthdate | with Fund | Served(1) | During Past 5 Years | Officer | ||||||
Gifford R. Zimmerman 333 West Wacker Drive Chicago, IL 60606 (9/9/56) |
Chief Administrative Officer |
Term: Annual Length of Service: Since 1988 |
Managing Director (since 2002), Assistant Secretary and Associate General Counsel, formerly, Vice President of Nuveen Investments, LLC; Managing Director (since 2002), Assistant Secretary and Associate General Counsel, formerly, Vice President of Nuveen Asset Management; Managing Director (since 2004) and Assistant Secretary (since 1994) of Nuveen Investments, Inc.; Vice President and Assistant Secretary of NWQ Investment Management Company, LLC (since 2002); Vice President and Assistant Secretary of Nuveen Investments Advisers Inc. (since 2002); Managing Director, Associate General Counsel and Assistant Secretary of Rittenhouse Asset Management, Inc. and Symphony Asset Management LLC (since 2003); Vice President and Assistant Secretary, Santa Barbara Asset Management LLC, Tradewinds Global Investors, LLC (since 2006); Nuveen HydePark Group, LLC and Richards & Tierney, Inc. (since 2007; previously, Managing Director (from 2002-2004), General Counsel and Assistant Secretary of Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp.(2); Chartered Financial Analyst. | 184 | ||||||
Williams Adams IV 333 West Wacker Drive Chicago, IL 60606 (6/9/55) |
Vice President | Term: Annual Length of Service: Since 2007 | Executive Vice President, U.S. Structured Products of Nuveen Investments, LLC (since 1999), prior thereto, Managing Director of Structured Investments. | 120 |
22
Number of |
||||||||||
Term of |
Portfolios |
|||||||||
Office and |
in Fund |
|||||||||
Position(s) |
Length of |
Complex |
||||||||
Name, Address |
Held |
Time |
Principal Occupation(s) |
Served by |
||||||
and Birthdate | with Fund | Served(1) | During Past 5 Years | Officer | ||||||
Cedric H. Antosiewicz 333 West Wacker Drive Chicago, IL 60606 (1/11/62) |
Vice President | Term: Annual Length of Service: Since 2007 | Managing Director (since 2004), previously, Vice President (1993-2004) of Nuveen Investments, LLC. | 120 | ||||||
Michael T. Atkinson 333 West Wacker Drive Chicago, IL 60606 (2/3/66) |
Vice President and Assistant Secretary | Term: Annual Length of Service: Since 2002 | Vice President (since 2002), formerly Assistant Vice President, formerly, Associate of Nuveen Investments, LLC. | 184 | ||||||
Peter H. DArrigo 333 West Wacker Drive Chicago, IL 60606 (11/28/67) |
Vice President and Treasurer | Term: Annual Length of Service: Since 1999 | Vice President and Treasurer (since 1999) of Nuveen Investments, LLC and of Nuveen Investments, Inc.; Vice President and Treasurer of Nuveen Asset Management (since 2002), Nuveen Investments Advisers Inc. (since 2002), NWQ Investments Management Company, LLC (since 2002), Rittenhouse Asset Management, Inc. (since 2003), Tradewinds Global Investors, LLC, Santa Barbara Asset Management, LLC, Nuveen HydePark Group LLC and Richards & Tierney, Inc. (since 2007); Treasurer of Symphony Asset Management LLC (since 2003); formerly, Vice President and Treasurer (from 1999 to 2004) of Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp.(2); Chartered Financial Analyst. | 184 | ||||||
Lorna C. Ferguson 333 West Wacker Drive Chicago, IL 60606 (10/24/45) |
Vice President | Term: Annual Length of Service: Since 1998 | Managing Director (since 2004), formerly, Vice President of Nuveen Investments, LLC; Managing Director of Nuveen Asset Management; formerly, Managing Director (2004), formerly, Vice President of Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp.(2) | 184 |
23
Number of |
||||||||||
Term of |
Portfolios |
|||||||||
Office and |
in Fund |
|||||||||
Position(s) |
Length of |
Complex |
||||||||
Name, Address |
Held |
Time |
Principal Occupation(s) |
Served by |
||||||
and Birthdate | with Fund | Served(1) | During Past 5 Years | Officer | ||||||
Stephen D. Foy 333 West Wacker Drive Chicago, IL 60606 (5/31/54) |
Vice President and Controller | Term: Annual Length of Service: Since 1993 | Vice President (since 1993) and Funds Controller (since 1998) of Nuveen Investments, LLC; Vice President of Nuveen Asset Management (since 2005); Vice President (since 1998), formerly, Funds Controller (1998-2003) of Nuveen Investments, Inc.; Certified Public Accountant. | 184 | ||||||
Walter M. Kelly 333 West Wacker Drive Chicago, IL 60606 (2/24/70) |
Chief Compliance Officer and Vice President | Term: Annual Length of Service: Since 2003 | Senior Vice President (since 2008) formerly, Vice President (2006-2008), formerly, Assistant Vice President and Assistant General Counsel of Nuveen Investments, LLC; Vice President (since 2006) and Assistant Secretary (since 2003) of Nuveen Asset Management; formerly, Assistant Vice President and Assistant Secretary of the Nuveen Funds (2003-2006). | 184 | ||||||
David J. Lamb 333 West Wacker Drive Chicago, IL 60606 (3/22/63) |
Vice President | Term: Annual Length of Service: Since 2000 | Vice President of Nuveen Investments, LLC (since 2000); Certified Public Accountant. | 184 | ||||||
Tina M. Lazar 333 West Wacker Drive Chicago, IL 60606 (8/27/61) |
Vice President | Term: Annual Length of Service: Since 2002 | Vice President of Nuveen Investments, LLC (since 1999). | 184 |
24
Number of |
||||||||||
Term of |
Portfolios |
|||||||||
Office and |
in Fund |
|||||||||
Position(s) |
Length of |
Complex |
||||||||
Name, Address |
Held |
Time |
Principal Occupation(s) |
Served by |
||||||
and Birthdate | with Fund | Served(1) | During Past 5 Years | Officer | ||||||
Larry W. Martin 333 West Wacker Drive Chicago, IL 60606 (7/27/51) |
Vice President and Assistant Secretary | Term: Annual Length of Service: Since 1988 | Vice President, Assistant Secretary and Assistant General Counsel of Nuveen Investments, LLC; Vice President, Assistant General Counsel and Assistant Secretary of Nuveen Investments, Inc.; Vice President (since 2005) and Assistant Secretary (since 1997) of Nuveen Asset Management; Vice President (since 2000), Assistant Secretary and Assistant General Counsel (since 1998) of Rittenhouse Asset Management, Inc.; Vice President and Assistant Secretary of Nuveen Investments Advisers Inc. (since 2002), NWQ Investment Management Company, LLC (since 2002), Symphony Asset Management LLC (since 2003), Tradewinds Global Investors, LLC, Santa Barbara Asset Management LLC (since 2006), Nuveen HydePark Group, LLC and Richards & Tierney, Inc. (since 2007); formerly, Vice President and Assistant Secretary of Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp.(2) | 184 |
25
Number of |
||||||||||
Term of |
Portfolios |
|||||||||
Office and |
in Fund |
|||||||||
Position(s) |
Length of |
Complex |
||||||||
Name, Address |
Held |
Time |
Principal Occupation(s) |
Served by |
||||||
and Birthdate | with Fund | Served(1) | During Past 5 Years | Officer | ||||||
Kevin J. McCarthy 333 West Wacker Drive Chicago, IL 60606 (3/26/66) |
Vice President and Secretary | Term: Annual Length of Service: Since 2007 | Managing Director (since 2008), Vice President (since 2007), Nuveen Investments, LLC; Managing Director (since 2008), Vice President and Assistant Secretary, (since 2007) Nuveen Asset Management, Rittenhouse Asset Management, Inc., Nuveen Investment Advisers Inc., Nuveen Investment Institutional Services Group LLC, NWQ Investment Management Company, LLC, Tradewinds Global Investors, LLC, NWQ Holdings, LLC, Symphony Asset Management LLC, Santa Barbara Asset Management, LLC, Nuveen HydePark Group, LLC and Richards & Tierney, Inc.; Vice President and Assistant General Counsel, Nuveen Investments, Inc. (since 2007); prior thereto, Partner, Bell, Boyd & Lloyd LLP (1997-2007). | 184 | ||||||
John V. Miller 333 West Wacker Drive Chicago, IL 60606 (4/10/67) |
Vice President | Term: Annual Length of Service: Since 2007 | Managing Director (since 2007), formerly, Vice President (2002-2007), prior thereto, Credit Analyst of Nuveen Asset Management and Nuveen Investments, LLC; Chartered Financial Analyst. | 184 | ||||||
James F. Ruane 333 West Wacker Drive Chicago, IL 60606 (7/3/62) |
Vice President and Assistant Secretary | Term: Annual Length of Service: Since 2007 | Vice President, Nuveen Investments (since 2007); prior thereto, Partner, Deloitte & Touche USA LLP (since 2005), formerly, senior tax manager (since 2002). | 184 |
26
Number of |
||||||||||
Term of |
Portfolios |
|||||||||
Office and |
in Fund |
|||||||||
Position(s) |
Length of |
Complex |
||||||||
Name, Address |
Held |
Time |
Principal Occupation(s) |
Served by |
||||||
and Birthdate | with Fund | Served(1) | During Past 5 Years | Officer | ||||||
Mark Winget 333 West Wacker Drive Chicago, IL 60606 (12/21/68) |
Vice President and Assistant Secretary | Term: Annual Length of Service: Since 2008 | Vice President, Nuveen Investments, LLC (since 2008); Vice President and Assistant Secretary, Nuveen Asset Management, Rittenhouse Asset Management, Inc., Nuveen Investment Advisers Inc., Nuveen Investment Institutional Services Group LLC, NWQ Investment Management Company, LLC, Tradewinds Global Investors, LLC, NWQ Holdings, LLC, Symphony Asset Management LLC, Santa Barbara Asset Management, LLC, Nuveen HydePark Group, LLC and Richards & Tierney, Inc. (since 2008); Vice President and Assistant General Counsel, Nuveen Investments, Inc. (since 2008); prior thereto, Counsel, Vedder Price P.C. (1997-2007). | 184 | ||||||
(1) | Length of Service indicates the year the individual became an officer of a fund in the Nuveen fund complex. | |
(2) | Nuveen Advisory Corp. and Nuveen Institutional Advisory Corp. were reorganized into Nuveen Asset Management, effective January 1, 2005. |
2. | Ratification of Independent Registered Public Accounting Firm for Core Equity |
27
3. | Approval of the Elimination of Fundamental Investment Policies and Approval of the New Fundamental Policy for Insured New York Premium, Insured Premium Income 2, Insured Municipal Opportunity, Premier Insured, Insured Quality, New York Quality, New York Select, Insured New York Tax-Free, Insured Dividend Advantage, Insured Tax-Free Advantage, New York Investment Quality and Insured New York Dividend |
28
29
30
31
32
33
34
Audit Fees(1) | Audit Related Fees | Tax Fees(2) | All Other Fees(3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adviser and |
Adviser and |
Adviser and |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fund | Fund | Adviser Entities | Fund | Adviser Entities | Fund | Adviser Entities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
|||||||||||||||||||||||||||||||||||||||||||||||
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
|||||||||||||||||||||||||||||||||||||||||||||||
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
|||||||||||||||||||||||||||||||||||||||||||||||
2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | |||||||||||||||||||||||||||||||||||||||||||||||
New York Dividend Advantage
|
$ | 11,312 | $ | 11,878 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 400 | $ | 500 | $ | 0 | $ | 0 | $ | 2,950 | $ | 1,550 | $ | 0 | $ | 0 | ||||||||||||||||||||||||||||||||
New York Dividend Advantage 2
|
9,665 | 10,161 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 1,550 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
New York Investment Quality
|
16,300 | 17,109 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
New York Municipal Value
|
9,819 | 10,346 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
New York Performance Plus
|
15,083 | 15,856 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
New York Quality Income
|
20,048 | 21,023 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
New York Select Quality
|
19,838 | 20,809 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured Dividend Advantage
|
23,278 | 24,467 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 1,550 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured Municipal Opportunity
|
54,258 | 56,946 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured Premium Income 2
|
25,811 | 27,178 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 1,550 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured Quality Income
|
28,568 | 30,015 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured Tax-Free Advantage
|
16,438 | 17,375 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 1,550 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured New York Dividend Advantage
|
10,589 | 11,140 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 1,550 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured New York Premium Income
|
10,823 | 11,377 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Insured New York Tax-Free Advantage
|
8,011 | 8,438 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 1,550 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Premier Insured
|
17,475 | 18,333 | 0 | 0 | 0 | 0 | 400 | 500 | 0 | 0 | 2,950 | 3,150 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Core Equity
|
N/A | 24,130 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
35
Audit Fees(1) | Audit Related Fees | Tax Fees(2) | All Other Fees(3) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fund | Fund | Adviser and Adviser Entities | Fund | Adviser and Adviser Entities | Fund | Adviser and Adviser Entities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
Fiscal |
|||||||||||||||||||||||||||||||||||||||||||||||
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
Year |
|||||||||||||||||||||||||||||||||||||||||||||||
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
Ended |
|||||||||||||||||||||||||||||||||||||||||||||||
2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | |||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Income
|
21,000 | 22,100 | 0 | 0 | 0 | 0 | 800 | 1,000 | 0 | 0 | 3,950 | 10,300 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Diversified Dividend and Income
|
29,000 | 31,000 | 0 | 0 | 0 | 0 | 800 | 1,000 | 0 | 0 | 950 | 7,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Equity Premium and Growth
|
16,367 | 17,770 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Equity Premium Advantage
|
20,019 | 21,313 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Equity Premium Income
|
24,959 | 26,994 | 0 | 0 | 0 | 0 | 21,232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Equity Premium Opportunity
|
36,207 | 38,759 | 0 | 0 | 0 | 0 | 932 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Quality Preferred Income
|
19,977 | 21,409 | 0 | 0 | 0 | 0 | 800 | 1,000 | 0 | 0 | 3,950 | 4,300 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Quality Preferred Income 2
|
30,313 | 32,473 | 0 | 0 | 0 | 0 | 800 | 1,000 | 0 | 0 | 3,950 | 4,300 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Quality Preferred Income 3
|
12,710 | 13,619 | 0 | 0 | 0 | 0 | 800 | 1,000 | 0 | 0 | 3,950 | 4,300 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Tax-Advantaged Total Return Strategy
|
23,000 | 24,600 | 0 | 0 | 0 | 0 | 800 | 1,000 | 0 | 0 | 1,550 | 1,650 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Tax-Advantaged Dividend Growth
|
N/A | 15,000 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Global Government Enhanced Income
|
29,200 | 25,199 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Global Value Opportunities
|
23,500 | 28,341 | 0 | 0 | 0 | 0 | 0 | 2,715 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Multi-Currency Short-Term Govt Income
|
N/A | 49,583 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Multi-Strategy Income and Growth
|
20,731 | 22,060 | 0 | 0 | 0 | 0 | 800 | 625 | 0 | 0 | 3,950 | 4,300 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Multi-Strategy Income and Growth 2
|
25,269 | 26,940 | 0 | 0 | 0 | 0 | 800 | 625 | 0 | 0 | 3,950 | 4,300 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
(1) | Audit Fees are the aggregate fees billed for professional services for the audit of the Funds annual financial statements and services provided in connection with statutory and regulatory filings or engagements. |
(2) | Tax Fees are the aggregate fees billed for professional services for tax advice, tax compliance and tax planning. |
(3) | All Other Fees are the aggregate fees billed for products and services for agreed-upon procedures engagements for leveraged Funds. |
36
Total Non-Audit Fees Billed to |
||||||||||||||||||||||||||||||||
Adviser and Adviser Entities |
||||||||||||||||||||||||||||||||
(Engagements Related |
Total Non-Audit Fees Billed to |
|||||||||||||||||||||||||||||||
Total Non-Audit |
Directly to the Operations and |
Adviser and Adviser Entities |
||||||||||||||||||||||||||||||
Fees Billed to Fund | Financial Reporting of Fund) | (All Other Engagements) | Total | |||||||||||||||||||||||||||||
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
|||||||||||||||||||||||||
Fund | Ended 2006 | Ended 2007 | Ended 2006 | Ended 2007 | Ended 2006 | Ended 2007 | Ended 2006 | Ended 2007 | ||||||||||||||||||||||||
New York Dividend Advantage
|
$ | 3,350 | $ | 2,050 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 3,350 | $ | 2,050 | ||||||||||||||||
New York Dividend Advantage 2
|
3,350 | 2,050 | 0 | 0 | 0 | 0 | 3,350 | 2,050 | ||||||||||||||||||||||||
New York Investment Quality
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
New York Municipal Value
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
New York Performance Plus
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
New York Quality Income
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
New York Select Quality
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
Insured Dividend Advantage
|
3,350 | 2,050 | 0 | 0 | 0 | 0 | 3,350 | 2,050 | ||||||||||||||||||||||||
Insured Municipal Opportunity
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
Insured Premium Income 2
|
3,350 | 2,050 | 0 | 0 | 0 | 0 | 3,350 | 2,050 | ||||||||||||||||||||||||
Insured Quality Income
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
Insured Tax-Free Advantage
|
3,350 | 2,050 | 0 | 0 | 0 | 0 | 3,350 | 2,050 | ||||||||||||||||||||||||
Insured New York Dividend Advantage
|
3,350 | 2,050 | 0 | 0 | 0 | 0 | 3,350 | 2,050 | ||||||||||||||||||||||||
Insured New York Premium Income
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
Insured New York Tax-Free Advantage
|
3,350 | 2,050 | 0 | 0 | 0 | 0 | 3,350 | 2,050 | ||||||||||||||||||||||||
Premier Insured
|
3,350 | 3,650 | 0 | 0 | 0 | 0 | 3,350 | 3,650 | ||||||||||||||||||||||||
Core Equity
|
N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | ||||||||||||||||||||||||
Real Estate Income
|
4,750 | 11,300 | 0 | 0 | 0 | 0 | 4,750 | 11,300 | ||||||||||||||||||||||||
37
Total Non-Audit Fees Billed to |
||||||||||||||||||||||||||||||||
Adviser and Adviser Entities |
||||||||||||||||||||||||||||||||
(Engagements Related |
Total Non-Audit Fees Billed to |
|||||||||||||||||||||||||||||||
Total Non-Audit |
Directly to the Operations and |
Adviser and Adviser Entities |
||||||||||||||||||||||||||||||
Fees Billed to Fund | Financial Reporting of Fund) | (All Other Engagements) | Total | |||||||||||||||||||||||||||||
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
Fiscal Year |
|||||||||||||||||||||||||
Fund | Ended 2006 | Ended 2007 | Ended 2006 | Ended 2007 | Ended 2006 | Ended 2007 | Ended 2006 | Ended 2007 | ||||||||||||||||||||||||
Diversified Dividend and Income
|
$ | 1,750 | $ | 8,000 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 1,750 | $ | 8,000 | ||||||||||||||||
Equity Premium and Growth
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Equity Premium Advantage
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Equity Premium Income
|
21,232 | 0 | 0 | 0 | 0 | 0 | 21,232 | 0 | ||||||||||||||||||||||||
Equity Premium Opportunity
|
932 | 0 | 0 | 0 | 0 | 0 | 932 | 0 | ||||||||||||||||||||||||
Quality Preferred Income
|
4,750 | 5,300 | 0 | 0 | 0 | 0 | 4,750 | 5,300 | ||||||||||||||||||||||||
Quality Preferred Income 2
|
4,750 | 5,300 | 0 | 0 | 0 | 0 | 4,750 | 5,300 | ||||||||||||||||||||||||
Quality Preferred Income 3
|
4,750 | 5,300 | 0 | 0 | 0 | 0 | 4,750 | 5,300 | ||||||||||||||||||||||||
Tax-Advantaged Total Return Strategy
|
2,350 | 2,650 | 0 | 0 | 0 | 0 | 2,350 | 2,650 | ||||||||||||||||||||||||
Tax-Advantaged Dividend Growth
|
N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | ||||||||||||||||||||||||
Global Government Enhanced Income
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||
Global Value Opportunities
|
0 | 2,715 | 0 | 0 | 0 | 0 | 0 | 2,715 | ||||||||||||||||||||||||
Multi-Currency Short-Term Govt Income
|
N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | ||||||||||||||||||||||||
Multi-Strategy Income and Growth
|
4,750 | 4,925 | 0 | 0 | 0 | 0 | 4,750 | 4,925 | ||||||||||||||||||||||||
Multi-Strategy Income and Growth 2
|
4,750 | 4,925 | 0 | 0 | 0 | 0 | 4,750 | 4,925 | ||||||||||||||||||||||||
38
39
40
41
Dollar Range of Equity Securities | ||||||||||||||||||||||||||||||||||||||||||||
New York |
New York |
Insured |
Insured |
Insured |
||||||||||||||||||||||||||||||||||||||||
Board Member Nominees/ |
New York |
New York |
Investment |
New York |
Performance |
New York |
New York |
Dividend |
Municipal |
Premium |
Insured |
|||||||||||||||||||||||||||||||||
Board Members | Dividend | Dividend 2 | Quality | Value | Plus | Quality | Select | Advantage | Opportunity | Income 2 | Quality | |||||||||||||||||||||||||||||||||
Nominees/Board Members who are not interested persons of the
Fund
|
||||||||||||||||||||||||||||||||||||||||||||
Robert P. Bremner
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Jack B. Evans
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
William C. Hunter
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
David J. Kundert
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
William J. Schneider
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Judith M. Stockdale
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Carole E. Stone
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Terence J.
Toth(2)
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Nominee who is an interested person of the Fund
|
||||||||||||||||||||||||||||||||||||||||||||
John P.
Amboian(2)
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 |
over $100,000 |
$50,001- $100,000 |
$ | 0 | ||||||||||||||||||||||||
A-1
Dollar Range of Equity Securities | ||||||||||||||||||||||||||||||||||||||||||||
Insured |
Insured |
Insured |
Insured |
Equity |
Equity |
|||||||||||||||||||||||||||||||||||||||
Board Member Nominees/ |
Tax-Free |
New York |
New York |
New York |
Premier |
Core |
Real |
Diversified |
Equity |
Premium |
Premium |
|||||||||||||||||||||||||||||||||
Board Members | Advantage | Dividend | Premium | Tax-Free | Insured | Equity | Estate | Dividend | Premium | Advantage | Income | |||||||||||||||||||||||||||||||||
Nominees/Board Members who are not interested persons of the
Fund
|
||||||||||||||||||||||||||||||||||||||||||||
Robert P. Bremner
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | Over $ | 100,000 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Jack B. Evans
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
William C. Hunter
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
David J. Kundert
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
William J. Schneider
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 1-$10,000 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Judith M. Stockdale
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Carole E. Stone
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Terence J.
Toth(2)
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||
Nominee who is an interested person of the Fund
|
||||||||||||||||||||||||||||||||||||||||||||
John P.
Amboian(2)
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 |
over $100,000 |
over $100,000 |
$ | 10,001-$50,000 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||||
A-2
Dollar Range of Equity Securities | ||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate Dollar |
||||||||||||||||||||||||||||||||||||||||||||||||
Range of Equity |
||||||||||||||||||||||||||||||||||||||||||||||||
Securities in |
||||||||||||||||||||||||||||||||||||||||||||||||
All Registered |
||||||||||||||||||||||||||||||||||||||||||||||||
Investment |
||||||||||||||||||||||||||||||||||||||||||||||||
Companies |
||||||||||||||||||||||||||||||||||||||||||||||||
Overseen by |
||||||||||||||||||||||||||||||||||||||||||||||||
Board Member |
||||||||||||||||||||||||||||||||||||||||||||||||
Nominees in |
||||||||||||||||||||||||||||||||||||||||||||||||
Board Member |
Equity |
Tax- |
Family of |
|||||||||||||||||||||||||||||||||||||||||||||
Nominees/Board |
Premium |
Quality |
Quality |
Quality |
Tax- |
Advantaged |
Global |
Global |
Multi- |
Multi- |
Multi- |
Investment |
||||||||||||||||||||||||||||||||||||
Members | Opportunity | Preferred | Preferred 2 | Preferred 3 | Advantaged | Dividend | Government | Value | Currency | Strategy | Strategy 2 | Companies(1) | ||||||||||||||||||||||||||||||||||||
Nominees/Board Members who are not interested persons of the
Funds
|
||||||||||||||||||||||||||||||||||||||||||||||||
Robert P. Bremner
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | Over $ | 100,000 | $ | 0 | $ | 0 |
Over $100,000 |
$ | 0 | $ | 10,001-$50,000 | $ | 0 | Over $ | 100,000 | |||||||||||||||||||||||||
Jack B. Evans
|
$ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | Over $ | 100,000 | ||||||||||||||||||||||||
William C. Hunter
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | Over $ | 100,000 | ||||||||||||||||||||||||
David J. Kundert
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | Over $ | 100,000 | ||||||||||||||||||||||||
William J. Schneider
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 1-$10,000 | $ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | Over $ | 100,000 | ||||||||||||||||||||||||
Judith M. Stockdale
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | $ | 0 | $ | 0 | $ | 1-$10,000 | Over $ | 100,000 | ||||||||||||||||||||||||
Carole E. Stone
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 10,001-$50,000 | ||||||||||||||||||||||||
Terence J.
Toth(2)
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||||||||||
Nominee who is an interested person of the Funds
|
||||||||||||||||||||||||||||||||||||||||||||||||
John P.
Amboian(2)
|
$ | 0 | $ | 0 | $ | 10,001-$50,000 | $ | 0 | $ | 0 | $ | 0 | $ | 0 |
Over $100,000 |
$ | 0 |
Over $ |
100,000 | $ | 0 | Over $ | 100,000 | |||||||||||||||||||||||||
(1) | The amounts reflect the aggregate dollar range of equity securities and the number of shares beneficially owned by the Board Member in the Funds and in all Nuveen funds overseen by each Board Member. |
(2) | In April 2008, Mr. Amboian and Mr. Toth were appointed to each Funds Board effective June 30, 2008. Mr. Toth did not own any shares of Nuveen Funds prior to becoming a Board Member. |
A-3
Fund Shares Owned By Board Member Nominees And Officers(1) | ||||||||||||||||||||||||||||||||||||||||||||
Board Member |
New York |
New York |
Insured |
Insured |
Insured |
|||||||||||||||||||||||||||||||||||||||
Nominees/Board |
New York |
New York |
Investment |
New York |
Performance |
New York |
New York |
Dividend |
Municipal |
Premium |
Insured |
|||||||||||||||||||||||||||||||||
Members | Dividend | Dividend 2 | Quality | Value | Plus | Quality | Select | Advantage | Opportunity | Income 2 | Quality | |||||||||||||||||||||||||||||||||
Nominees/Board Members who are not interested persons of the
Funds
|
||||||||||||||||||||||||||||||||||||||||||||
Robert P. Bremner
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Jack B. Evans
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
William C. Hunter
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
David J. Kundert
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
William J. Schneider
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Judith M. Stockdale
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Carole E. Stone
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Terence J.
Toth(2)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Nominee who is an interested person of the Funds
|
||||||||||||||||||||||||||||||||||||||||||||
John P.
Amboian(2)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 154 | 10,000 | 0 | |||||||||||||||||||||||||||||||||
All Board Member Nominees and Officers as a Group
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,960 | 10,000 | 0 | |||||||||||||||||||||||||||||||||
A-4
Fund Shares Owned By Board Member Nominees And Officers(1) | ||||||||||||||||||||||||||||||||||||||||||||
Insured |
Insured |
Insured |
Insured |
Equity |
Equity |
|||||||||||||||||||||||||||||||||||||||
Board Member Nominees/ |
Tax-Free |
New York |
New York |
New York |
Premier |
Core |
Real |
Diversified |
Equity |
Premium |
Premium |
|||||||||||||||||||||||||||||||||
Board Members | Advantage | Dividend | Premium | Tax-Free | Insured | Equity | Estate | Dividend | Premium | Advantage | Income | |||||||||||||||||||||||||||||||||
Nominees/Board Members who are not interested persons of the
Fund
|
||||||||||||||||||||||||||||||||||||||||||||
Robert P. Bremner
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 13,200 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Jack B. Evans
|
0 | 0 | 0 | 0 | 0 | 0 | 1,100 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
William C. Hunter
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
David J. Kundert
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
William J. Schneider
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 664 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Judith M. Stockdale
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,152 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Carole E. Stone
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Terence J.
Toth(2)
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Nominee who is an interested person of the Fund
|
||||||||||||||||||||||||||||||||||||||||||||
John P.
Amboian(2)
|
0 | 0 | 0 | 0 | 0 | 11,500 | 10,000 | 3,500 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
All Board Member Nominees and Officers as a Group
|
0 | 0 | 0 | 0 | 0 | 12,500 | 58,400 | 18,016 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
A-5
Fund Shares Owned By Board Member Nominees And Officers(1) | ||||||||||||||||||||||||||||||||||||||||||||
Board Member |
Equity |
Tax- |
||||||||||||||||||||||||||||||||||||||||||
Nominees/ |
Premium |
Quality |
Quality |
Quality |
Tax- |
Advantaged |
Global |
Global |
Multi- |
Multi- |
Multi- |
|||||||||||||||||||||||||||||||||
Board Members | Opportunity | Preferred | Preferred 2 | Preferred 3 | Advantaged | Dividend | Government | Value | Currency | Strategy | Strategy 2 | |||||||||||||||||||||||||||||||||
Nominees/Board Members who are not interested persons of the
Fund
|
||||||||||||||||||||||||||||||||||||||||||||
Robert P. Bremner
|
0 | 0 | 0 | 0 | 12,500 | 0 | 0 | 12,500 | 0 | 3,500 | 0 | |||||||||||||||||||||||||||||||||
Jack B. Evans
|
0 | 0 | 4,400 | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 0 | |||||||||||||||||||||||||||||||||
William C. Hunter
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
David J. Kundert
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
William J. Schneider
|
0 | 0 | 0 | 0 | 0 | 0 | 511 | 0 | 0 | 1,023 | 0 | |||||||||||||||||||||||||||||||||
Judith M. Stockdale
|
0 | 0 | 0 | 0 | 0 | 0 | 672 | 0 | 0 | 0 | 638 | |||||||||||||||||||||||||||||||||
Carole E. Stone
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Terence J. Toth
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
Nominee who is an interested person of the Fund
|
||||||||||||||||||||||||||||||||||||||||||||
John P.
Amboian(2)
|
0 | 0 | 1,000 | 0 | 0 | 0 | 0 | 11,000 | 0 | 16,000 | 0 | |||||||||||||||||||||||||||||||||
All Board Members Nominees/Officers as a Group
|
1,400 | 0 | 5,400 | 0 | 123,445 | 2,000 | 1,183 | 107,301 | 0 | 24,823 | 39,638 | |||||||||||||||||||||||||||||||||
(1) | The numbers include share equivalents of certain Nuveen funds in which the Board Member is deemed to be invested pursuant to the Deferred Compensation Plan for Independent Board Members as more fully described below. |
(2) | In April 2008, Mr. Amboian and Mr. Toth were appointed to each Funds Board effective June 30, 2008. Mr. Toth did not own shares of Nuveen Funds prior to being appointed as a Board Member. |
A-6
Compliance, Risk |
||||||||||||||||||||||||||||
Management |
Nominating |
|||||||||||||||||||||||||||
and Regulatory |
and |
|||||||||||||||||||||||||||
Regular |
Special |
Executive |
Dividend |
Oversight |
Audit |
Governance |
||||||||||||||||||||||
Board |
Board |
Committee |
Committee |
Committee |
Committee |
Committee |
||||||||||||||||||||||
Fund | Meeting | Meeting | Meeting | Meeting | Meeting | Meeting | Meeting | |||||||||||||||||||||
Nuveen New York Dividend Advantage Municipal Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen New York Dividend Advantage Municipal Fund 2
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen New York Investment Quality Municipal Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen New York Municipal Value Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen New York Performance Plus Municipal Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen New York Quality Income Municipal Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen New York Select Quality Municipal Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured Dividend Advantage Municipal Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured Municipal Opportunity Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured Premium Income Municipal Fund 2
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured Quality Municipal Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured Tax-Free Advantage Municipal Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured New York Dividend Advantage Municipal Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured New York Premium Income Municipal Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Insured New York Tax-Free Advantage Municipal Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Premier Insured Municipal Income Fund, Inc.
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Core Equity Alpha Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Real Estate Income Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Diversified Dividend and Income Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Equity Premium and Growth Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Equity Premium Advantage Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Equity Premium Income Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Equity Premium Opportunity Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
B-1
Compliance, Risk |
||||||||||||||||||||||||||||
Management |
Nominating |
|||||||||||||||||||||||||||
and Regulatory |
and |
|||||||||||||||||||||||||||
Regular |
Special |
Executive |
Dividend |
Oversight |
Audit |
Governance |
||||||||||||||||||||||
Board |
Board |
Committee |
Committee |
Committee |
Committee |
Committee |
||||||||||||||||||||||
Fund | Meeting | Meeting | Meeting | Meeting | Meeting | Meeting | Meeting | |||||||||||||||||||||
Nuveen Quality Preferred Income Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Quality Preferred Income Fund 2
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Quality Preferred Income Fund 3
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Tax-Advantaged Total Return Strategy Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Tax-Advantaged Dividend Growth Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Global Government Enhanced Income Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Global Value Opportunities Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Multi-Currency Short-Term Government Income Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Multi-Strategy Income & Growth Fund
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
Nuveen Multi-Strategy Income & Growth Fund 2
|
4 | 10 | 1 | 5 | 4 | 4 | 4 | |||||||||||||||||||||
B-2
I. | Organization and Membership |
II. | Statement of Policy, Purpose and Processes |
C-1
1. | Reviewing and discussing the annual audited financial statements and semi-annual financial statements with Fund management and the independent auditors including major issues regarding accounting and auditing principles and practices, and the Funds disclosures in its periodic reports under Managements Discussion and Analysis. | |
2. | Requiring the independent auditors to deliver to the Chairman of the Audit Committee a timely report on any issues relating to the significant accounting policies, management judgments and accounting estimates or other matters that would need to be communicated under Statement on Auditing Standards (SAS) No. 90, Audit Committee Communications (which amended SAS No. 61, Communication with Audit Committees), that arise during the auditors review of the Funds financial statements, which information the Chairman shall further communicate to the other members of the Audit Committee, as deemed necessary or appropriate in the chairmans judgment. | |
3. | Discussing with management the Funds press releases regarding financial results and dividends, as well as financial information and earnings guidance provided to analysts and rating agencies. This discussion may be done generally, consisting of discussing the types of information to be disclosed and the types of presentations to be made. The Chairman of the Audit Committee shall be authorized to have these discussions with management on behalf of the Audit Committee. |
C-2
4. | Discussing with management and the independent auditors (a) significant financial reporting issues and judgments made in connection with the preparation and presentation of the Funds financial statements, including any significant changes in the Funds selection or application of accounting principles and any major issues as to the adequacy of the Funds internal controls and any special audit steps adopted in light of material control deficiencies; and (b) analyses prepared by Fund management and/or the independent auditor setting forth significant financial reporting issues and judgments made in connection with the preparation of the financial statements, including analyses of the effects of alternative GAAP methods on the financial statements. | |
5. | Discussing with management and the independent auditors the effect of regulatory and accounting initiatives on the Funds financial statements. | |
6. | Reviewing and discussing reports, both written and oral, from the independent auditors and/or Fund management regarding (a) all critical accounting policies and practices to be used; (b) all alternative treatments of financial information within generally accepted accounting principles that have been discussed with management, ramifications of the use of such alternative treatments and disclosures, and the treatment preferred by the independent auditors; and (c) other material written communications between the independent auditors and management, such as any management letter or schedule of unadjusted differences. | |
7. | Discussing with Fund management the Funds major financial risk exposures and the steps management has taken to monitor and control these exposures, including the Funds risk assessment and risk management policies and guidelines. In fulfilling its obligations under this paragraph, the Audit Committee may review in a general manner the processes other Board committees have in place with respect to risk assessment and risk management. | |
8. | Reviewing disclosures made to the Audit Committee by the Funds principal executive officer and principal financial officer during their certification process for the Funds periodic reports about any significant deficiencies in the design or operation of internal controls or material weaknesses therein and any fraud involving management or other employees who have a significant role in the Funds internal controls. In fulfilling its obligations under this paragraph, the Audit Committee may review in a general manner the processes other Board committees have in place with respect to deficiencies in internal controls, material weaknesses, or any fraud associated with internal controls. |
1. | Selecting, appointing, retaining or replacing the independent auditors, subject, if applicable, only to Board and shareholder ratification; and compensating, evaluating and overseeing the work of the independent auditor (including the resolution of disagreements between Fund management and the independent auditor regarding financial reporting). | |
2. | Meeting with the independent auditors and Fund management to review the scope, fees, audit plans and staffing for the audit, for the current year. At the conclusion of the audit, reviewing such audit results, including the independent auditors |
C-3
evaluation of the Funds financial and internal controls, any comments or recommendations of the independent auditors, any audit problems or difficulties and managements response, including any restrictions on the scope of the independent auditors activities or on access to requested information, any significant disagreements with management, any accounting adjustments noted or proposed by the auditor but not made by the Fund, any communications between the audit team and the audit firms national office regarding auditing or accounting issues presented by the engagement, any significant changes required from the originally planned audit programs and any adjustments to the financial statements recommended by the auditors. |
3. | Pre-approving all audit services and permitted non-audit services, and the terms thereof, to be performed for the Funds by their independent auditors, subject to the de minimis exceptions for non-audit services described in Section 10A of the Exchange Act that the Audit Committee approves prior to the completion of the audit, in accordance with any policies or procedures relating thereto as adopted by the Board or the Audit Committee. The Chairman of the Audit Committee shall be authorized to give pre-approvals of such non-audit services on behalf of the Audit Committee. | |
4. | Obtaining and reviewing a report or reports from the independent auditors at least annually (including a formal written statement delineating all relationships between the auditors and the Funds consistent with Independent Standards Board Standard 1, as may be amended, restated, modified or replaced) regarding (a) the independent auditors internal quality-control procedures; (b) any material issues raised by the most recent internal quality-control review, or peer review, of the firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years, respecting one or more independent audits carried out by the firm; (c) any steps taken to deal with any such issues; and (d) all relationships between the independent auditor and the Funds and their affiliates, in order to assist the Audit Committee in assessing the auditors independence. After reviewing the foregoing report[s] and the independent auditors work throughout the year, the Audit Committee shall be responsible for evaluating the qualifications, performance and independence of the independent auditor and their compliance with all applicable requirements for independence and peer review, and a review and evaluation of the lead partner, taking into account the opinions of Fund management and the internal auditors, and discussing such reports with the independent auditors. The Audit Committee shall present its conclusions with respect to the independent auditor to the Board. | |
5. | Reviewing any reports from the independent auditors mandated by Section 10A(b) of the Exchange Act regarding any illegal act detected by the independent auditors (whether or not perceived to have a material effect on the Funds financial statements) and obtaining from the independent auditors any information about illegal acts in accordance with Section 10A(b). | |
6. | Ensuring the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law, and further considering the rotation of the independent auditor firm itself. |
C-4
7. | Establishing and recommending to the Board for ratification policies for the Funds, Fund management or the Fund advisers hiring of employees or former employees of the independent auditor who participated in the audits of the Funds. | |
8. | Taking, or recommending that the Board take, appropriate action to oversee the independence of the outside auditor. |
1. | Reviewing the proposed programs of the internal auditor for the coming year. It is not the obligation or responsibility of the Audit Committee to confirm the independence of any Nuveen internal auditors performing services relating to the Funds or to approve any termination or replacement of the Nuveen Manager of Internal Audit. | |
2. | Receiving a summary of findings from any completed internal audits pertaining to the Funds and a progress report on the proposed internal audit plan for the Funds, with explanations for significant deviations from the original plan. |
1. | The Board has responsibilities regarding the pricing of a Funds securities under the 1940 Act. The Board has delegated this responsibility to the Committee to address valuation issues that arise between Board meetings, subject to the Boards general supervision of such actions. The Committee is primarily responsible for the oversight of the Pricing Procedures and actions taken by the internal Valuation Group (Valuation Matters). The Valuation Group will report on Valuation Matters to the Committee and/or the Board of Directors/Trustees, as appropriate. | |
2. | Performing all duties assigned to it under the Funds Pricing Procedures, as such may be amended from time to time. | |
3. | Periodically reviewing and making recommendations regarding modifications to the Pricing Procedures as well as consider recommendations by the Valuation Group regarding the Pricing Procedures. | |
4. | Reviewing any issues relating to the valuation of a Funds securities brought to the Committees attention, including suspensions in pricing, pricing irregularities, price overrides, self-pricing, NAV errors and corrections thereto, and other pricing matters. In this regard, the Committee should consider the risks to the Funds in assessing the possible resolutions of these Valuation Matters. | |
5. | Evaluating, as it deems necessary or appropriate, the performance of any pricing agent and recommend changes thereto to the full Board. | |
6. | Reviewing any reports or comments from examinations by regulatory authorities relating to Valuation Matters of the Funds and consider managements responses to any such comments and, to the extent the Committee deems necessary or appropriate, propose to management and/or the full Board the modification of the Funds policies and procedures relating to such matters. The Committee, if deemed necessary or desirable, may also meet with regulators. |
C-5
7. | Meeting with members of management of the Funds, outside counsel, or others in fulfilling its duties hereunder, including assessing the continued appropriateness and adequacy of the Pricing Procedures, eliciting any recommendations for improvements of such procedures or other Valuation Matters, and assessing the possible resolutions of issues regarding Valuation Matters brought to its attention. | |
8. | Performing any special review, investigations or oversight responsibilities relating to Valuation as requested by the Board of Directors/Trustees. | |
9. | 9. Investigating or initiating an investigation of reports of improprieties or suspected improprieties in connection with the Funds policies and procedures relating to Valuation Matters not otherwise assigned to another Board committee. |
1. | Reviewing with counsel to the Funds, counsel to Nuveen, the Fund advisers counsel and independent counsel to the Board legal matters that may have a material impact on the Funds financial statements or compliance policies. | |
2. | Receiving and reviewing periodic or special reports issued on exposure/controls, irregularities and control failures related to the Funds. | |
3. | Reviewing with the independent auditors, with any internal auditor and with Fund management, the adequacy and effectiveness of the accounting and financial controls of the Funds, and eliciting any recommendations for the improvement of internal control procedures or particular areas where new or more detailed controls or procedures are desirable. Particular emphasis should be given to the adequacy of such internal controls to expose payments, transactions or procedures that might be deemed illegal or otherwise improper. | |
4. | Reviewing the reports of examinations by regulatory authorities as they relate to financial statement matters. | |
5. | Discussing with management and the independent auditor any correspondence with regulators or governmental agencies that raises material issues regarding the Funds financial statements or accounting policies. | |
6. | Obtaining reports from management with respect to the Funds policies and procedures regarding compliance with applicable laws and regulations. | |
7. | Reporting regularly to the Board on the results of the activities of the Audit Committee, including any issues that arise with respect to the quality or integrity of the Funds financial statements, the Funds compliance with legal or regulatory requirements, the performance and independence of the Funds independent auditors, or the performance of the internal audit function. | |
8. | Performing any special reviews, investigations or oversight responsibilities requested by the Board. | |
9. | Reviewing and reassessing annually the adequacy of this charter and recommending to the Board approval of any proposed changes deemed necessary or advisable by the Audit Committee. |
C-6
10. | Undertaking an annual review of the performance of the Audit Committee | |
11. | Establishing procedures for the receipt, retention and treatment of complaints received by the Funds regarding accounting, internal accounting controls or auditing matters, and the confidential, anonymous submission of concerns regarding questionable accounting or auditing matters by employees of Fund management, the investment adviser, administrator, principal underwriter, or any other provider of accounting related services for the Funds, as well as employees of the Funds. |
C-7
www.nuveen.com | NAN0608 |
1. | Automated Touch Tone Voting: Call toll-free 1-888-221-0697 and follow the recorded
instructions. |
|
2. | On the Internet at www.proxyweb.com, and follow the simple instructions. |
|
3. | Sign, Date and Return this proxy card using the enclosed postage-paid envelope. |
FUND NAME PRINTS HERE
|
THIS PROXY IS SOLICITED BY THE BOARD OF THE FUND | |
COMMON STOCK
|
FOR AN ANNUAL MEETING OF SHAREHOLDERS, JUNE 30, 2008 |
ê | ê | NIO-ETF-MN-JUNE-MM |
ê | Please
fill in box(es) as shown using black or blue ink or number 2
pencil. PLEASE DO NOT USE FINE POINT PENS. |
x | ê |
1. Election of Board Members: | FOR | WITHHOLD | ||||||
NOMINEES | AUTHORITY | |||||||
(01) Robert P. Bremner | (03) John P. Amboian | (05) Judith M. Stockdale | listed at left | to vote for | ||||
(02) Jack B. Evans | (04) David J. Kundert | (06) Carole E. Stone | (except as | all nominees | ||||
(07) Terence J. Toth | marked to | listed at left | ||||||
the contrary) | ||||||||
o | o | |||||||
FOR | AGAINST | ABSTAIN | ||||||||||||||
3a(i). | Approve the elimination of
the fundamental policy relating to insured/ uninsured bonds. |
o | o | o | ||||||||||||
3b. | Approve the fundamental
policy relating to tax-exempt securities. |
o | o | o | ||||||||||||
4. | To transact such other business as may properly come before the Annual Meeting. |
ê | NIO-ETF-MN-JUNE-MM | ê |
1. | Automated Touch Tone Voting: Call toll-free 1-888-221-0697 and follow the recorded
instructions. |
|
2. | On the Internet at www.proxyweb.com, and follow the simple instructions. |
|
3. | Sign, Date and Return this proxy card using the enclosed postage-paid envelope. |
FUND NAME PRINTS HERE
|
THIS PROXY IS SOLICITED BY THE BOARD OF THE FUND | |
MUNIPREFERRED SHARES
|
FOR AN ANNUAL MEETING OF SHAREHOLDERS, JUNE 30, 2008 | |
ê | ê | NIO-ETF-MN-JUNE-MM |
ê | Please
fill in box(es) as shown using black or blue ink or number 2
pencil. PLEASE DO NOT USE FINE POINT PENS. |
x | ê |
FOR | WITHHOLD | |||||||
NOMINEES | AUTHORITY | |||||||
listed at left | to vote for | |||||||
(except as | all nominees | |||||||
marked to | listed at left | |||||||
1. Election of Board Members: | the contrary) | |||||||
Preferred Shares Only | ||||||||
(01) Robert
P. Bremner |
(04) David J. Kundert | (08) William C. Hunter | o | o | ||||
(02)
Jack B. Evans |
(05) Judith M. Stockdale | (09) William J. Schneider | ||||||
(03) John P. Amboian |
(06) Carole E. Stone | |||||||
(07) Terence J. Toth |
FOR | AGAINST | ABSTAIN | ||||||||||||||
3a(i). | Approve the elimination of
the fundamental policy relating to insured/ uninsured bonds. |
o | o | o | ||||||||||||
3b. | Approve the fundamental
policy relating to tax-exempt securities. |
o | o | o | ||||||||||||
4. |